Omega Fund IV GP, L.P.'s Net Worth

Estimate Recalculated Sep 9, 2024 12:35AM EST

Who is Omega Fund IV GP, L.P.

Omega Fund IV GP, L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Kezar Life Sciences, Inc., Replimune Group, Inc., Translate Bio, Inc., Paratek Pharmaceuticals, Inc., and Nuvation Bio Inc..

SEC CIK

Omega Fund IV GP, L.P.'s CIK is 0001528383

Past Insider Trading and Trends

No data available

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Kezar Life Sciences, Inc.

Investor

Updated Jun 25, 2018

View Quote Details


Form 4	—	—	—	—	Jun 25, 2018	1.39M	Options	—	Jun 25
Form 3	—	—	—	—	Jun 20, 2018	—	—	—	—

Showing 2 results

Replimune Group, Inc.

Investor

Updated Mar 16, 2022

View Quote Details


Form 4	-1.11%	-106.50K	$12.64	-$1.50M	Mar 16, 2022	9.45M	Sale	—	Mar 14 - Mar 16
Form 4	-0.94%	-45.42K	$34.58	-$1.57M	Nov 23, 2021	4.76M	Sale	Scheduled	Nov 19 - Nov 22
Form 4	-0.05%	-2.59K	$33.50	-$86.90K	Nov 18, 2021	4.81M	Sale	Scheduled	Nov 16 - Nov 18
Form 4	-0.05%	-2.59K	$33.50	-$86.90K	Nov 18, 2021	4.81M	Sale	Scheduled	Nov 16 - Nov 18
Form 4	-0.50%	-24.02K	$33.66	-$808.41K	Nov 16, 2021	4.81M	Sale	Scheduled	Nov 12 - Nov 15
Form 4	-0.38%	-18.29K	$33.61	-$614.73K	Nov 12, 2021	4.84M	Sale	Scheduled	Nov 10 - Nov 11
Form 4	-0.23%	-11.35K	$33.66	-$382.21K	Nov 10, 2021	4.85M	Sale	Scheduled	Nov 08 - Nov 09
Form 4	-0.63%	-31.02K	$33.57	-$1.04M	Nov 08, 2021	4.87M	Sale	Scheduled	Nov 04 - Nov 05
Form 4	-0.25%	-12.17K	$33.58	-$408.70K	Sep 27, 2021	4.90M	Sale	Scheduled	Sep 23
Form 4	-2.00%	-100.00K	$32.99	-$3.30M	Sep 20, 2021	4.91M	Sale	Scheduled	Sep 16 - Sep 17
Form 4	—	16.50K	—	—	Apr 05, 2021	16.50K	Grant	—	Apr 01
Form 4	-0.10%	-5.25K	$45.00	-$236.20K	Feb 11, 2021	5.14M	Sale	Scheduled	Feb 08
Form 4	-0.57%	-30.35K	$45.42	-$1.38M	Jan 28, 2021	5.28M	Sale	Scheduled	Jan 26
Form 4	-0.21%	-11.36K	$45.04	-$511.66K	Jan 26, 2021	5.31M	Sale	Scheduled	Jan 22
Form 4	-0.37%	-19.58K	$45.10	-$883.05K	Jan 19, 2021	5.33M	Sale	Scheduled	Jan 14 - Jan 15
Form 4	—	16.50K	—	—	Apr 03, 2020	16.50K	Grant	—	Apr 01
Form 4	4.31%	220.00K	$13.61	$2.99M	Nov 20, 2019	5.33M	Purchase	—	Nov 18
Form 4	—	13.50K	—	—	Apr 03, 2019	13.50K	Grant	—	Apr 01
Form 4	952.30%	4.63M	$15.00	$4.00M	Jul 25, 2018	5.12M	Purchase	—	Jul 19 - Jul 24
Form 3	—	—	—	—	Jul 19, 2018	—	—	—	—

Showing 20 results

Translate Bio, Inc.

Investor

Updated Jul 03, 2018


Form 4	-82.00%	-22.21M	—	—	Jul 03, 2018	4.88M	Options	—	Jul 02
Form 3	—	—	—	—	Jun 27, 2018	—	—	—	—

Showing 2 results

Paratek Pharmaceuticals, Inc.

Investor

Updated Nov 10, 2014


Form 3	—	—	—	—	Nov 10, 2014	10.93M	—	—	—

Showing 1 results

Nuvation Bio Inc.

Investor

Updated Dec 17, 2021

View Quote Details


Form 4	-2.13%	-500.00K	$10.07	-$5.03M	Dec 17, 2021	22.96M	Sale	—	Dec 15

Showing 1 results